Abstract |
Although Miller Fisher syndrome cases have been published in this coronavirus disease 2019 (COVID-19) pandemic, anti-GQ1b antibody has not been identified so far. A direct proof of association is not yet available since the exact pathophysiology is not known. Using a proof of contradiction argument, lack of GQ1b serves as the indirect proof that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is probably the infection preceding demyelination. A novel antigen has yet to be described.
|
Authors | Surina Kajani, Raheem Kajani, Chin-Wei Huang, Tu Tran, Antonio K Liu |
Journal | Cureus
(Cureus)
Vol. 13
Issue 1
Pg. e12424
(Jan 01 2021)
ISSN: 2168-8184 [Print] United States |
PMID | 33409112
(Publication Type: Case Reports)
|
Copyright | Copyright © 2021, Kajani et al. |